Pregnyl

Product manufactured by Organon Usa Inc.

Application Nr Approved Date Route Status External Links
BLA017692 None None None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

Indications And Usage Hcg Has Not Been Demonstrated To Be Effective Adjunctive Therapy In The Treatment Of Obesity. There Is No Substantial Evidence That It Increases Weight Loss Beyond That Resulting From Caloric Restriction, That It Causes A More Attractive Or "normal" Distribution Of Fat, Or That It Decreases The Hunger And Discomfort Associated With Calorie-Restricted Diets. Prepubertal Cryptorchidism Not Due To Anatomical Obstruction. In General, Hcg Is Thought To Induce Testicular Descent In Situations When Descent Would Have Occurred At Puberty. Hcg Thus May Help Predict Whether Or Not Orchiopexy Will Be Needed In The Future. Although, In Some Cases, Descent Following Hcg Administration Is Permanent, In Most Cases, The Response Is Temporary. Therapy Is Usually Instituted In Children Between The Ages Of 4 And 9. Selected Cases Of Hypogonadotropic Hypogonadism (Hypogonadism Secondary To A Pituitary Deficiency) In Males. Induction Of Ovulation And Pregnancy In The Anovulatory, Infertile Woman In Whom The Cause Of Anovulation Is Secondary And Not Due To Primary Ovarian Failure, And Who Has Been Appropriately Pretreated With Human Menotropins.

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Choriogonadotropin Alfa

Comments